1. Home
  2. SLND vs PLX Comparison

SLND vs PLX Comparison

Compare SLND & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Southland Holdings Inc.

SLND

Southland Holdings Inc.

HOLD

Current Price

$3.50

Market Cap

178.6M

Sector

Industrials

ML Signal

HOLD

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

HOLD

Current Price

$1.75

Market Cap

204.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLND
PLX
Founded
1900
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
178.6M
204.9M
IPO Year
N/A
1998

Fundamental Metrics

Financial Performance
Metric
SLND
PLX
Price
$3.50
$1.75
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
$4.00
$12.00
AVG Volume (30 Days)
50.6K
522.3K
Earning Date
11-12-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.07
Revenue
$935,461,000.00
$61,840,000.00
Revenue This Year
N/A
$14.29
Revenue Next Year
$0.96
$16.65
P/E Ratio
N/A
$25.92
Revenue Growth
N/A
35.41
52 Week Low
$2.68
$1.32
52 Week High
$5.34
$3.10

Technical Indicators

Market Signals
Indicator
SLND
PLX
Relative Strength Index (RSI) 46.27 44.67
Support Level $3.48 $1.74
Resistance Level $3.92 $1.85
Average True Range (ATR) 0.25 0.09
MACD 0.04 0.02
Stochastic Oscillator 35.52 51.35

Price Performance

Historical Comparison
SLND
PLX

About SLND Southland Holdings Inc.

Southland Holdings Inc is an infrastructure construction company in North America. The company's infrastructure projects range from water conveyance systems and tunnels to long-span bridges and vertical structures. The company operates in two distinct segments: Civil and Transportation. The civil segment operates throughout North America and specializes in services that include the design and construction of water pipelines, pump stations, lift stations, water and wastewater treatment plants, concrete and structural steel, outfall, and tunneling. The transportation segment operates throughout North America and specializes in services that include the design and construction of bridges, roadways, marine, dredging, ship terminals and piers, and specialty structures and facilities.

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.

Share on Social Networks: